初级渐进性多发性硬化 - - 了解和管理疾病进展的关键
Izabela Sempik1, Edyta Dziadkowiak2, Helena Moreira3
1Department of Neurology, Regional Hospital in Legnica, Iwaszkiewicza 5, 59-220 Legnica, Poland.
International journal of molecular sciences
|August 29, 2024
概括
初级渐进性多发性硬化症 (PPMS) 是一种罕见的MS类型,预后不佳. 对PPMS的研究提供了关于疾病进展的见解,以及潜在的治疗目标,以更好地管理.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 临床神经科学 临床神经科学
背景情况:
- 初级渐进性多发性硬化症 (PPMS) 是最不常见的多发性硬化症 (MS).
- PPMS呈现出独特的临床症状和不良预后,往往需要广泛的诊断工作.
- 尽管取得了进展,但诊断和管理PPMS仍然具有挑战性,阻碍了有效的治疗策略.
研究的目的:
- 审查目前关于PPMS的证据,涵盖其背景,临床特征和诊断标记.
- 探索PPMS中中枢神经系统 (CNS) 损伤的潜在机制.
- 总结治疗机会,包括批准的治疗方法和未来的研究方向.
主要方法:
- 关于PPMS研究的综合文献综述.
- 对研究中枢神经系统损伤过程在PPMS中的研究分析.
- 综合有关PPMS生物标志物和治疗干预措施的信息.
主要成果:
- PPMS涉及慢性免疫媒介炎症,神经退行症和功能障碍的复髓化.
- 确定了潜在的临床,生化和放射性生物标志物,用于监测和预测PPMS进展.
- 总结了当前的治疗选择,正在进行的试验和未来的研究途径.
结论:
- 了解PPMS机制可以阐明MS的进展情况,并为临床实践提供信息.
- 生物标志物对于评估结果和指导PPMS个性化治疗至关重要.
- 对PPMS的进一步研究可能会导致管理疾病进展的新型治疗点.
相关概念视频
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454


